Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
+$4.76B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.4B |
| 4 |
Amazon
AMZN
|
+$1.22B |
| 5 |
Broadcom
AVGO
|
+$1.21B |
Top Sells
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$181M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$150M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$110M |
Sector Composition
| 1 | Technology | 31.06% |
| 2 | Financials | 12.83% |
| 3 | Healthcare | 11.53% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2926
Mercer International
MERC
$206M
| $3.56M | ﹤0.01% |
525,532
+8,957
| +2% | +$60.7K |
|
2927
Achieve Life Sciences
ACHV
$157M
| $3.55M | ﹤0.01% |
749,109
+48,474
| +7% | +$230K |
|
2928
CS Disco
LAW
$357M
| $3.54M | ﹤0.01% |
602,699
-6,677
| -1% | -$39.3K |
|
2929
Solid Biosciences
SLDB
$420M
| $3.52M | ﹤0.01% |
504,870
-8,616
| -2% | -$60.1K |
|
2930
Arq
ARQ
$306M
| $3.5M | ﹤0.01% |
596,468
+4,545
| +0.8% | +$26.7K |
|
2931
MBIA
MBI
$393M
| $3.5M | ﹤0.01% |
980,450
-62,950
| -6% | -$225K |
|
2932
Crawford & Co Class A
CRD.A
$527M
| $3.5M | ﹤0.01% |
318,801
+25,752
| +9% | +$283K |
|
2933
XBiotech
XBIT
$83.8M
| $3.5M | ﹤0.01% |
452,264
+22,059
| +5% | +$171K |
|
2934
First Western Financial
MYFW
$228M
| $3.49M | ﹤0.01% |
174,570
+2,661
| +2% | +$53.2K |
|
2935
J. Jill
JILL
$273M
| $3.47M | ﹤0.01% |
140,762
+31,265
| +29% | +$771K |
|
2936
Zynex
ZYXI
$44.8M
| $3.47M | ﹤0.01% |
425,509
+26,774
| +7% | +$219K |
|
2937
Dakota Gold
DC
$540M
| $3.44M | ﹤0.01% |
1,458,553
+60,918
| +4% | +$144K |
|
2938
Forge Global Holdings
FRGE
$239M
| $3.43M | ﹤0.01% |
174,659
+1,261
| +0.7% | +$24.8K |
|
2939
Global Water Resources
GWRS
$271M
| $3.43M | ﹤0.01% |
272,509
+8,593
| +3% | +$108K |
|
2940
Ginkgo Bioworks
DNA
$593M
| $3.4M | ﹤0.01% |
416,631
+33,824
| +9% | +$276K |
|
2941
Medallion Financial
MFIN
$244M
| $3.39M | ﹤0.01% |
416,956
+9,849
| +2% | +$80.2K |
|
2942
Smith Douglas Homes
SDHC
$993M
| $3.39M | ﹤0.01% |
89,581
-245
| -0.3% | -$9.26K |
|
2943
Smith-Midland
SMID
$211M
| $3.38M | ﹤0.01% |
101,193
+1,866
| +2% | +$62.3K |
|
2944
Oppenheimer Holdings
OPY
$806M
| $3.38M | ﹤0.01% |
65,967
-8,918
| -12% | -$456K |
|
2945
Cardlytics
CDLX
$59.6M
| $3.37M | ﹤0.01% |
1,053,178
+73,484
| +8% | +$235K |
|
2946
Holley
HLLY
$370M
| $3.36M | ﹤0.01% |
1,137,811
+55,641
| +5% | +$164K |
|
2947
Bel Fuse Class A
BELFA
$1.5B
| $3.35M | ﹤0.01% |
33,694
+2,778
| +9% | +$276K |
|
2948
PLAYSTUDIOS Inc
MYPS
$121M
| $3.34M | ﹤0.01% |
2,211,020
+215,347
| +11% | +$325K |
|
2949
The Joint Corp
JYNT
$154M
| $3.34M | ﹤0.01% |
291,581
+3,043
| +1% | +$34.8K |
|
2950
Lineage Cell Therapeutics
LCTX
$306M
| $3.33M | ﹤0.01% |
3,679,280
+83,274
| +2% | +$75.4K |
|